+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin use in patients with chronic kidney disease stages 2-4: targeting beyond improved mortality rates



Statin use in patients with chronic kidney disease stages 2-4: targeting beyond improved mortality rates



International Urology and Nephrology 42(3): 711-713




(PDF emailed within 0-6 h: $19.90)

Accession: 055911488

Download citation: RISBibTeXText

PMID: 20044779

DOI: 10.1007/s11255-009-9677-z


Related references

Statin Effects on Exacerbation Rates, Mortality, and Inflammatory Markers in Patients with Chronic Obstructive Pulmonary Disease: A Review of Prospective Studies. PharmacoTherapy 36(5): 536-547, 2016

Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrology, Dialysis, Transplantation 25(4): 1183-1191, 2010

Impact of elevated intact parathyroid hormone on mortality and renal disease progression in patients with chronic kidney disease stages 3 and 4. Current Medical Research and Opinion 28(9): 1527-1536, 2013

Comparative efficacy and adverse effects of the addition of ezetimibe to statin versus statin titration in chronic kidney disease patients. Therapeutic Advances in Cardiovascular Disease 7(6): 306-315, 2014

Do Implantable Cardioverter Defibrillators Reduce Mortality in Patients With Chronic Kidney Disease at All Stages?. International Heart Journal 58(3): 371-377, 2017

Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease. Brazilian Journal of Medical and Biological Research 0: 0-0, 2014

Any grade of relative overhydration is associated with long-term mortality in patients with Stages 4 and 5 non-dialysis chronic kidney disease. Clinical Kidney Journal 11(3): 372-376, 2018

Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe. Kidney International 93(6): 1432-1441, 2018

Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrology, Dialysis, Transplantation, 2018

Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clinical Journal of the American Society of Nephrology 2(6): 1241-1248, 2007

Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia. Journal of Diabetes 8(4): 502-507, 2015

Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clinical Kidney Journal 10(2): 170-175, 2017

Association between periodontitis and mortality in stages 3-5 chronic kidney disease: NHANES III and linked mortality study. Journal of Clinical Periodontology 43(2): 104-113, 2017

Statin Use during Hospitalization and Short-Term Mortality in Acute Ischaemic Stroke with Chronic Kidney Disease. European Neurology 79(5-6): 296-302, 2018

Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5. Advances in Chronic Kidney Disease 14(1): 105-112, 2007